In case ANOVA yielded a significant effect, Tukeys HSD test was used for post hoc comparisons
Is there a cancer risk with IGF-1 LR3 supplement
Sources Epidemiology and Clinical Outcomes of Vasomotor Symptoms Among Perimenopausal Women in the US: a Systematic Review Prevalence and Severity of Symptoms Across the Menopause Transition: Findings from the AMY Study Tirzepatide Prescribing Information - Drug Interactions: Oral Hormonal Contraceptives (FDA) Semaglutide Prescribing Information - Adverse Reactions (FDA, 2025) Wilding JPH et al
Adding more water lowers the concentration in each syringe unit but does not change the total amount in the vial
KLOW is a four-peptide research blend containing BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg) and KPV (10mg)
References: [1] Falutz J, Potvin D, Mamputu JC, Assaad H, Zoltowska M, Michaud SE, Berger D, Somero M, Moyle G, Brown S, Martorell C, Turner R, Grinspoon S